Skip to main content

Dow, Synpromics Collaborate on Synthetic Promoter Development

NEW YORK (GenomeWeb News) –Dow AgroSciences will develop synthetic promoter firm Synpromics' technology for applications in plant science under a collaboration announced today.

An initial proof of concept project with Dow Agro has begun to demonstrate the applicability of Synpromics' technology in certain crops, Synpromics said. Financial and other terms of the deal were not disclosed.

"Technologies such as those developed by Synpromics can significantly enhance Dow AgroSciences' tool kit for developing improved crops," Daniel Kittle, vice president of R&D for Dow AgroSciences, said in a statement. "Synthetic promoters in the agricultural industry have significant potential to accelerate the gene discovery and product development of new traits."

Based in Edinburgh, Scotland, Synpromics develops synthetic promoters for applications in diagnostics development, gene therapeutics, and research use. A synthetic promoter is a regulatory DNA sequence created by picking out the regulatory regions in a gene, chopping them up, and then putting them back together.

Filed under

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.